Any 0 3 0 3 O
other 4 9 4 9 O
medical 10 17 10 17 B-chronic_disease
condition 18 27 18 27 I-chronic_disease
that 28 32 28 32 O
, 32 33 32 33 O
in 34 36 34 36 O
the 37 40 37 40 O
opinion 41 48 41 48 O
of 49 51 49 51 O
the 52 55 52 55 O
investigator 56 68 56 68 O
, 68 69 68 69 O
might 70 75 70 75 O
interfere 76 85 76 85 O
with 86 90 86 90 O
the 91 94 91 94 O
patient 95 102 95 102 O
's 102 104 102 104 O
participation 105 118 105 118 O
in 119 121 119 121 O
the 122 125 122 125 O
study 126 131 126 131 O
, 131 132 131 132 O
poses 133 138 133 138 O
an 139 141 139 141 O
added 142 147 142 147 O
risk 148 152 148 152 O
for 153 156 153 156 O
the 157 160 157 160 O
patient 161 168 161 168 O
, 168 169 168 169 O
or 170 172 170 172 O
confound 173 181 173 181 O
the 182 185 182 185 O
assessment 186 196 186 196 O
of 197 199 197 199 O
the 200 203 200 203 O
patient 204 211 204 211 O

Any 0 3 212 215 O
systemic 4 12 216 224 B-chronic_disease
bacterial 13 22 225 234 I-chronic_disease
or 23 25 235 237 O
other 26 31 238 243 O
infection 32 41 244 253 B-chronic_disease
, 41 42 253 254 O
which 43 48 255 260 O
is 49 51 261 263 O
clinically 52 62 264 274 O
significant 63 74 275 286 O
in 75 77 287 289 O
the 78 81 290 293 O
opinion 82 89 294 301 O
of 90 92 302 304 O
the 93 96 305 308 O
investigator 97 109 309 321 O
and 110 113 322 325 O
has 114 117 326 329 O
not 118 121 330 333 O
been 122 126 334 338 O
treated 127 134 339 346 O
with 135 139 347 351 O
appropriate 140 151 352 363 O
antibiotics 152 163 364 375 B-treatment

Body 0 4 376 380 O
weight 5 11 381 387 B-clinical_variable
≥10 12 15 388 391 O
kg 16 18 392 394 I-lower_bound

CMS 0 3 395 398 O
subtype 4 11 399 406 O
diagnosis 12 21 407 416 O
of 22 24 417 419 O
acetylcholinesterase 25 45 420 440 B-chronic_disease
deficiency 46 56 441 451 I-chronic_disease
, 56 57 451 452 O
slow 58 62 453 457 B-chronic_disease
- 62 63 457 458 I-chronic_disease
channel 63 70 458 465 I-chronic_disease
syndrome 71 79 466 474 I-chronic_disease
, 79 80 474 475 O
LRP4 81 85 476 480 B-chronic_disease
deficiency 86 96 481 491 I-chronic_disease
, 96 97 491 492 O
and 98 101 493 496 O
plectin 102 109 497 504 B-chronic_disease
deficiency 110 120 505 515 I-chronic_disease

Cardiac 0 7 516 523 B-chronic_disease
conduction 8 18 524 534 I-chronic_disease
defects 19 26 535 542 I-chronic_disease
on 27 29 543 545 O
Screening 30 39 546 555 O
ECG 40 43 556 559 B-treatment

Female 0 6 560 566 B-gender
patients 7 15 567 575 I-gender
of 16 18 576 578 O
childbearing 19 31 579 591 O
potential 32 41 592 601 O
must 42 46 602 606 O
have 47 51 607 611 O
a 52 53 612 613 O
negative 54 62 614 622 B-pregnancy
pregnancy 63 72 623 632 I-pregnancy
test 73 77 633 637 O
( 78 79 638 639 O
serum 79 84 639 644 O
human 85 90 645 650 O
chorionic 91 100 651 660 O
gonadotropin 101 113 661 673 O
[ 114 115 674 675 O
HCG 115 118 675 678 O
] 118 119 678 679 O
at 120 122 680 682 O
Screening 123 132 683 692 O
) 132 133 692 693 O

Genetically 0 11 694 705 O
- 11 12 705 706 O
confirmed 12 21 706 715 O
CMS 22 25 716 719 B-chronic_disease
involving 26 35 720 729 O
acetylcholine 36 49 730 743 B-chronic_disease
receptor 50 58 744 752 I-chronic_disease
defect 59 65 753 759 I-chronic_disease
, 65 66 759 760 O
Rapsyn 67 73 761 767 B-chronic_disease
deficiency 74 84 768 778 I-chronic_disease
, 84 85 778 779 O
MuSK 86 90 780 784 B-chronic_disease
deficiency 91 101 785 795 I-chronic_disease
, 101 102 795 796 O
Dok-7 103 108 797 802 B-chronic_disease
deficiency 109 119 803 813 I-chronic_disease
, 119 120 813 814 O
SYT2 121 125 815 819 B-chronic_disease
deficiency 126 136 820 830 I-chronic_disease
, 136 137 830 831 O
SNAP25B 137 144 831 838 B-chronic_disease
deficiency 145 155 839 849 I-chronic_disease
, 155 156 849 850 O
and 157 160 851 854 O
fast 161 165 855 859 B-chronic_disease
channel 166 173 860 867 I-chronic_disease
syndrome 174 182 868 876 I-chronic_disease

History 0 7 877 884 O
of 8 10 885 887 O
drug 11 15 888 892 O
allergy 16 23 893 900 O
to 24 26 901 903 O
any 27 30 904 907 O
pyridine 31 39 908 916 B-allergy_name
- 39 40 916 917 I-allergy_name
containing 40 50 917 927 I-allergy_name
substances 51 61 928 938 I-allergy_name
or 62 64 939 941 O
any 65 68 942 945 O
amifampridine 69 82 946 959 B-allergy_name
phosphate 83 92 960 969 I-allergy_name
excipient(s 93 104 970 981 O
) 104 105 981 982 O

In 0 2 983 985 O
patients 3 11 986 994 O
naïve 12 17 995 1000 O
to 18 20 1001 1003 O
3,4 21 24 1004 1007 B-treatment
- 24 25 1007 1008 I-treatment
DAP 25 28 1008 1011 I-treatment
or 29 31 1012 1014 O
amifampridine 32 45 1015 1028 B-treatment
phosphate 46 55 1029 1038 I-treatment
, 55 56 1038 1039 O
improvement 57 68 1040 1051 O
of 69 71 1052 1054 O
> 72 73 1055 1056 O
20 73 75 1056 1058 B-lower_bound
% 75 76 1058 1059 I-lower_bound
in 77 79 1060 1062 O
MFM20 80 85 1063 1068 B-clinical_variable
or 86 88 1069 1071 I-clinical_variable
MFM32 89 94 1072 1077 I-clinical_variable
scores 95 101 1078 1084 I-clinical_variable
after 102 107 1085 1090 O
open 108 112 1091 1095 O
label 113 118 1096 1101 O
period 119 125 1102 1108 O
of 126 128 1109 1111 O
up 129 131 1112 1114 O
titration 132 141 1115 1124 O
of 142 144 1125 1127 O
dose 145 149 1128 1132 O

In 0 2 1133 1135 O
patients 3 11 1136 1144 O
previously 12 22 1145 1155 O
stabilized 23 33 1156 1166 O
on 34 36 1167 1169 O
3,4 37 40 1170 1173 B-treatment
- 40 41 1173 1174 I-treatment
DAP 41 44 1174 1177 I-treatment
or 45 47 1178 1180 I-treatment
amifampridine 48 61 1181 1194 I-treatment
phosphate 62 71 1195 1204 I-treatment
, 71 72 1204 1205 O
history 73 80 1206 1213 O
of 81 83 1214 1216 O
meaningful 84 94 1217 1227 O
improvement 95 106 1228 1239 O
in 107 109 1240 1242 O
motor 110 115 1243 1248 O
function 116 124 1249 1257 O
( 125 126 1258 1259 O
in 126 128 1259 1261 O
opinion 129 136 1262 1269 O
of 137 139 1270 1272 O
investigator 140 152 1273 1285 O
) 152 153 1285 1286 O

MFM 0 3 1287 1290 B-clinical_variable
20 4 6 1291 1293 O
or 7 9 1294 1296 O
32 10 12 1297 1299 O
score 13 18 1300 1305 O
equal 19 24 1306 1311 O
or 25 27 1312 1314 O
less 28 32 1315 1319 O
than 33 37 1320 1324 O
48 38 40 1325 1327 B-lower_bound
or 41 43 1328 1330 O
76 44 46 1331 1333 B-lower_bound
, 46 47 1333 1334 O
respectively 48 60 1335 1347 O
, 60 61 1347 1348 O
at 62 64 1349 1351 O
Screening 65 74 1352 1361 O

Male 0 4 1362 1366 B-gender

Pregnancy 0 9 1367 1376 B-pregnancy

Seizure 0 7 1377 1384 B-chronic_disease
disorder 8 16 1385 1393 I-chronic_disease

Treatment 0 9 1394 1403 B-treatment
with 10 14 1404 1408 I-treatment
an 15 17 1409 1411 I-treatment
investigational 18 33 1412 1427 I-treatment
drug 34 38 1428 1432 I-treatment
( 39 40 1433 1434 O
other 40 45 1434 1439 O
than 46 50 1440 1444 O
amifampridine 51 64 1445 1458 B-treatment
phosphate 65 74 1459 1468 I-treatment
) 74 75 1468 1469 O
, 75 76 1469 1470 O
device 77 83 1471 1477 B-treatment
, 83 84 1477 1478 O
or 85 87 1479 1481 O
biological 88 98 1482 1492 B-treatment
agent 99 104 1493 1498 I-treatment
within 105 111 1499 1505 O
30 112 114 1506 1508 B-upper_bound
days 115 119 1509 1513 I-upper_bound
before 120 126 1514 1520 O
Screening 127 136 1521 1530 O
or 137 139 1531 1533 O
while 140 145 1534 1539 O
participating 146 159 1540 1553 O
in 160 162 1554 1556 O
this 163 167 1557 1561 O
study 168 173 1562 1567 O

Willingness 0 11 1568 1579 O
of 12 14 1580 1582 O
patients 15 23 1583 1591 O
receiving 24 33 1592 1601 O
pyridostigmine 34 48 1602 1616 B-treatment
, 48 49 1616 1617 O
prednisone 50 60 1618 1628 B-treatment
, 60 61 1628 1629 O
albuterol 62 71 1630 1639 B-treatment
, 71 72 1639 1640 O
ephedrine 73 82 1641 1650 B-treatment
, 82 83 1650 1651 O
or 84 86 1652 1654 O
fluoxetine 87 97 1655 1665 B-treatment
to 98 100 1666 1668 O
remain 101 107 1669 1675 O
on 108 110 1676 1678 O
a 111 112 1679 1680 O
stable 113 119 1681 1687 O
dose 120 124 1688 1692 O
of 125 127 1693 1695 O
these 128 133 1696 1701 O
medications 134 145 1702 1713 B-treatment
throughout 146 156 1714 1724 O
the 157 160 1725 1728 O
study 161 166 1729 1734 O
interval 167 175 1735 1743 O

age 0 3 1744 1747 B-age
2 4 5 1748 1749 B-lower_bound
and 6 9 1750 1753 O
above 10 15 1754 1759 O

female 0 6 1760 1766 B-gender

must 0 4 1767 1771 O
practice 5 13 1772 1780 B-contraception_consent
effective 14 23 1781 1790 I-contraception_consent
, 23 24 1790 1791 I-contraception_consent
reliable 25 33 1792 1800 I-contraception_consent
contraceptive 34 47 1801 1814 I-contraception_consent
regimen 48 55 1815 1822 I-contraception_consent
during 56 62 1823 1829 O
the 63 66 1830 1833 O
study 67 72 1834 1839 O

planning 0 8 1840 1848 O
to 9 11 1849 1851 O
become 12 18 1852 1858 O
pregnant 19 27 1859 1867 B-pregnancy
at 28 30 1868 1870 O
any 31 34 1871 1874 O
time 35 39 1875 1879 O
during 40 46 1880 1886 O
the 47 50 1887 1890 O
study 51 56 1891 1896 O

